bio.org/investorforum • #BIOBIF16

October 18-19, 2016 • San Francisco, CA

INVESTORFORUM

900+ attendees

1,700+ partnering meetings scheduled, a 22% INCREASE since 2014

175 private and public company presentations

295 partnering companies, an 18% INCREASE over 2014

Audience Demographics

The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2017.

HOTEL INFORMATIONThe Westin St. Francis 335 Powell Street San Francisco, CA 94102

ProgramThe BIO Investor Forum delivers a rich program that features corporate presentations and panel debates on the sweet spots and growth challenges facing the industry. The BIO Investor Forum features:

• Public and venture-stage company presentations.

• Expert-led workshops on the latest market and investment opportunities with emphasis on drug and technology development.

• BIO One-on-One Partnering™ meetings.

• Premier opportunity to network with industry executives and investors focused exclusively on life sciences.

Why Investors Attend• HEAR from and meet with executives at the top life sciences

growth companies.

• EVALUATE fresh investment opportunities including compatible, complementary and competitive companies.

• BENEFIT from candid panel discussions with leading clinical experts and investigators with insights on pipeline research and clinical practice.

• GET A ‘BIG PICTURE’ OVERVIEW of the industry and the issues affecting product innovation, capitalization, and commercialization.

Target Audience• Private equity and public investors, research analysts, and industry

executives focused on investment and business development opportunities in the life sciences.

Why Companies Attend• MEET one-on-one with new and current investors, analysts, and

partnering companies.

• GET THE PULSE on the latest life sciences investment trends from sophisticated investment and company executives.

• SHOWCASE your company story in presentations to qualified investors.

• NETWORK with peers, investors and potential partners.

bio.org/investorforum • #BIOBIF16

October 18-19, 2016 • San Francisco

INVESTORFORUM

2015 BIO Investor Forum Advisory Committee

John Chambers

ROTH Capital Partners

Stephen T. IsaacsAduro Biotech

Julie PapanekCanaan Partners

David WoodhouseNGM Biopharmaceuticals

Sara RadcliffeCalifornia Life Sciences Association (CLSA)

Vikas Goyal, MBASR One

Charlotte HubbertBill and Melinda Gates Foundation

Arlene MorrisWillow Advisors

Cayce DentonTPG Biotech

Jason HaflerSanofi-Genzyme BioVentures

Paulina HillPolaris Partners

Jennifer Landress, CMPBiocom

Jit PatelJuvenile Diabetes Research Foundation (JDRF)

John PoulosAbbVie

Asish K. Xavier, PhDJ&J Development Corporation

October 18-19, 2016 • San Francisco, CA

For more information, contact Melissa Arndorfer at marndorfer@bio.org or at 202-962-9512